Explore Your Options. Understand the Evidence. Make an Informed Decision.
Regenerative medicine is an evolving area of healthcare that investigates how cells, tissues, and biological products may support the body’s natural repair processes.
At A Brighter Future Healthcare Services, our approach begins with education—not promises. We help patients understand their symptoms, review conventional and emerging care options, discuss the available evidence, and determine whether a regenerative-medicine consultation is an appropriate next step.
Regenerative products and procedures vary significantly in their composition, regulation, evidence, risks, and permitted uses. A consultation does not guarantee eligibility or treatment.
Start With the Question That Matters Most
What are you hoping to improve?
Joint and Mobility Concerns
Learn about evaluation options for persistent knee, hip, shoulder, or other joint symptoms.
Sports and Overuse Injuries
Discuss symptoms associated with athletic activity, repetitive use, tendon strain, or delayed recovery.
Back and Spine Concerns
Explore the importance of accurate diagnosis before considering any procedure for back pain or spinal symptoms.
Recovery and Physical Performance
Review evidence-based strategies for recovery, conditioning, nutrition, rehabilitation, and appropriate medical care.
Healthy Aging
Discuss mobility, strength, metabolic health, nutrition, and other factors that contribute to maintaining function over time.
I’m Not Sure
Begin with a comprehensive consultation so the ABF team can better understand your symptoms and goals.
What Is Regenerative Medicine?
Regenerative medicine is a broad field that studies approaches intended to restore, replace, repair, or support damaged cells and tissues.
The term may include:
- Cellular therapies
- Human-cell or tissue products
- Platelet-based procedures
- Tissue-engineering approaches
- Certain gene therapies
- Other biological or investigational products
These categories are not interchangeable. Products described online as “stem cells,” “cord tissue,” “Wharton’s jelly,” “exosomes,” “growth factors,” or “orthobiologics” can differ substantially in what they contain and how they are regulated.
For that reason, patients should never evaluate a regenerative procedure based on the words “stem cell therapy” alone.
Stem Cells, Explained Simply
Stem cells are cells with the ability to self-renew and, under certain biological conditions, develop into specialized cell types.
They play important roles in human development, blood formation, and tissue maintenance. Researchers continue to study whether specific stem-cell products can be used safely and effectively for additional medical purposes.
However, the behavior of naturally occurring stem cells inside the body should not be treated as proof that every commercial product marketed as a stem-cell treatment can repair damaged tissue or improve a medical condition.
The source of the cells, processing method, intended use, dosage, route of administration, supporting research, and regulatory status all matter.
Not All Regenerative Products Are the Same
Understanding Common Product Categories
What Does ABF Currently Offer?
At ABF, we believe in complete transparency regarding the products we use. During your consultation, we provide verified information containing:
Product Identification
- • Commercial product name
- • Manufacturer or processing laboratory
- • Tissue or cellular source
- • Whether the product contains viable cells
- • Lot-tracking process
- • Donor-screening standards
- • Sterility and infectious-disease testing
- • Certificate-of-analysis process
Regulatory Information
- • FDA approval or licensure status
- • Investigational new drug number, when applicable
- • Clinical-trial identifier, when applicable
- • Human-cell or tissue-product classification
- • Claimed homologous use
- • Applicable prescribing or patient information
- • Any restrictions on marketing, administration, or intended use
Administration Information
- • Route of administration
- • Intended anatomical location
- • Provider qualifications
- • Imaging guidance, when applicable
- • Required monitoring
- • Emergency and adverse-event protocols
Required Patient Disclosure
We clearly disclose whether the proposed use is FDA approved, investigational under FDA authorization, not FDA approved for the proposed purpose, or offered under another legally reviewed regulatory pathway.
Conditions and Symptoms Requiring Evaluation
Patients often contact regenerative-medicine clinics because they are experiencing:
- Persistent knee discomfort
- Hip or shoulder symptoms
- Osteoarthritis
- Tendon or ligament injuries
- Back or neck pain
- Reduced mobility
- Sports-related injuries
- Slow recovery after physical activity
- General concerns about aging and physical function
These concerns are reasons to seek an evaluation—not proof that a regenerative product is appropriate. The same symptom can have multiple causes, and some require urgent, surgical, neurological, rheumatological, orthopedic, rehabilitative, or other specialized care.
ABF’s evaluation process should focus first on identifying the likely source of the patient’s symptoms and reviewing established treatment options.
What Regenerative Procedures Cannot Promise
Regenerative-medicine marketing should never guarantee that a procedure will:
- Regrow cartilage
- Rebuild a spinal disc
- Reverse arthritis
- Eliminate inflammation
- Repair a torn tendon or ligament
- Avoid surgery
- Restore youthful function
- Cure a neurological condition
- Produce permanent pain relief
- Work after a specific number of days
- Replace established medical treatment
Patient experiences, testimonials, laboratory findings, and biological theories do not establish that a treatment is safe or effective for every patient.
ABF’s Education-First Approach
No Pressure. No Guarantees. No One-Size-Fits-All Protocols.
Regenerative medicine can be difficult to evaluate because the language used in marketing is often more confident than the evidence. ABF’s role is to help each patient understand:
Your Regenerative Medicine Evaluation
A More Responsible Path to Treatment Decisions
Tell Us What You Are Experiencing
Complete a secure questionnaire describing the location of your symptoms, when they began, previous injuries, current pain or mobility limitations, treatments already attempted, relevant diagnoses, current medications, and your functional goals.
Complete a Clinical Review
The ABF team reviews your medical history, current symptoms, medications, risk factors, and prior treatment records.
Obtain Appropriate Diagnostic Information
Depending on the concern, the provider may request previous medical records, X-rays, MRI or other imaging, laboratory studies, specialist notes, physical-therapy records, or a new diagnostic evaluation.
Review All Reasonable Options
Your consultation should include discussion of appropriate alternatives, which may include activity modification, physical therapy, strength and mobility programs, weight management, oral or topical medications, injections, orthopedic or specialist referral, surgical evaluation, watchful waiting, or participation in an authorized clinical trial.
Make an Informed Decision
When a regenerative option is discussed, ABF should explain the exact product, its regulatory status, the intended purpose, the quality of supporting evidence, known and theoretical risks, expected recovery requirements, costs and refund policies, and follow-up and adverse-event procedures.
Who May Request a Consultation?
A consultation may be appropriate for adults who:
- Have persistent musculoskeletal symptoms
- Want a more complete explanation of their diagnosis
- Have tried conservative care without sufficient improvement
- Want to understand non-surgical and surgical options
- Are interested in regenerative-medicine research
- Are willing to consider the risks, uncertainties, and financial implications
- Understand that consultation does not guarantee treatment
A person may not qualify for a procedure because of medical risk, insufficient evidence, an inappropriate diagnosis, product limitations, regulatory restrictions, or the availability of safer and better-supported treatment options.
Reasons Treatment May Be Postponed or Declined
Depending on the procedure and product, additional caution may be necessary for patients with:
- Active infection, fever or acute illness
- Cancer or a history requiring specialist review
- Bleeding disorders or use of anticoagulant medication
- Significant immune-system disorders
- Pregnancy or breastfeeding
- Severe heart, kidney, or liver disease
- Uncontrolled diabetes or blood pressure
- Neurological warning signs or progressive weakness
- Loss of bowel or bladder control
- Recent surgery or inability to complete follow-up care
This list is not exhaustive. Final eligibility requires individualized clinical assessment.
Questions Every Patient Should Ask
Use this interactive checklist to prepare for any regenerative medicine consultation.
About the Product
About Regulation
About Evidence
About Safety
About Cost
Potential Risks
Risks depend on the product, processing, delivery method, treatment location, and individual patient. Possible risks may include:
- Pain or Bleeding
- Bruising or Infection
- Nerve or Vascular injury
- Allergic or immune reaction
- Unwanted inflammation
- Contamination
- Transmission of infectious disease
- Failure to improve
- Worsening symptoms
- Delayed access to effective treatment
- Tissue growth in an unintended location
- Abnormal cell growth or tumor formation
- Complications requiring emergency care
The absence of an immediate complication does not establish long-term safety.
What Results Should Patients Expect?
There is no responsible way to promise a particular result before understanding the diagnosis, severity, patient health, treatment history, product characteristics, route of administration, rehabilitation plan, quality of evidence, and duration of follow-up.
A consultation should distinguish between:
- A theoretical biological mechanism
- Laboratory or animal research
- Early human research
- Patient testimonials
- Controlled clinical evidence
- FDA-approved indications
These are different levels of evidence and should not be presented as equivalent.
Regenerative Medicine and Surgery
Regenerative procedures should not be advertised as a guaranteed alternative to surgery.
Some patients may appropriately explore non-surgical options before surgery. Others may need timely surgical evaluation to prevent additional damage or loss of function.
ABF should coordinate referral when a patient’s symptoms, imaging, diagnosis, or neurological findings suggest that specialty or surgical care may be necessary.
Supportive Care at ABF
When clinically appropriate, a broader recovery plan may include:
- Primary-care coordination
- Medical weight-management support
- Nutrition counseling and physical-activity guidance
- IV hydration for appropriate wellness purposes
- Emsculpt Neo® muscle-conditioning services
- Emtone® wellness and body-treatment services
- Mental-health and stress-management support
- Referral to physical therapy, orthopedics, pain management, or another specialist
These services should not be represented as making an unapproved regenerative product more effective.
Patient Education Resources
Learn at your own pace before making a decision.
Stem Cells Made Simple
Download ABF’s educational guide to learn:
- • What stem cells are and how products differ
- • What FDA approval means
- • What questions to ask a clinic
- • How to evaluate research claims and risks
- • How to prepare for a consultation
Regenerative Medicine Webinar
Attend ABF’s educational webinar for a patient-friendly discussion of:
- • Stem-cell fundamentals and product categories
- • Evidence versus marketing
- • Regulatory considerations and potential risks
- • Questions patients should ask
- • How ABF approaches consultation and referral
The webinar should not include product-specific treatment recommendations or imply that attendance establishes candidacy.
Register for the Free WebinarFrequently Asked Questions.
Request a Regenerative Medicine Consultation
Clarity Before Commitment
A regenerative-medicine decision should begin with a diagnosis, an honest discussion of the evidence, and full disclosure of regulatory status, risks, alternatives, and cost.
Complete the secure consultation request to tell ABF what symptoms you are experiencing, what treatments you have already tried, what records or imaging are available, what questions you want answered, and what you hope to regain or improve.
A Brighter Future Healthcare Services, Inc.
1521 Owen Park Lane
Fayetteville, NC 28304
Office
910-321-6006Required Website Disclaimer
Regenerative medicine is an evolving field. Products marketed as stem cells, cord blood, cord tissue, Wharton’s jelly, amniotic products, exosomes, or related biologics may not be FDA approved for the proposed use.
A Brighter Future Healthcare Services does not guarantee that a regenerative product or procedure will relieve symptoms, repair tissue, prevent surgery, reverse aging, or treat a disease or medical condition.
Patients should receive written information identifying the exact product, regulatory status, supporting evidence, known and potential risks, treatment alternatives, and total cost before consenting to any procedure.
Information on this website is educational and does not constitute a diagnosis, treatment recommendation, or guarantee of eligibility.